Journal of Pathology 2014-10-01

Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.

Caihong Zeng, Yun Fan, Junnan Wu, Shaolin Shi, Zhaohong Chen, Yongzhong Zhong, Changming Zhang, Ke Zen, Zhihong Liu

Index: J. Pathol. 234(2) , 203-13, (2014)

Full Text: HTML

Abstract

The progression of podocytopathies is quite variable among patients and the underlying reason for this remains unclear. Here, we report that autophagic activity in podocytes plays a critical role in controlling the progression of podocytopathies. Morphological and biochemical studies on renal biopsies from patients with minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS) showed that glomeruli, and in particular podocytes, from MCD patients had higher levels of Beclin1-mediated autophagic activity than glomeruli from FSGS patients. Repeat renal biopsies of MCD patients enabled tracking of podocyte autophagic activity and confirmed that patients maintaining high podocyte autophagic activity retained MCD status, whereas patients with decreased podocyte autophagic activity progressed to FSGS. Inhibition of autophagic activity, by knocking down Beclin1 or by treating with 3-methyladenine (3-MA) or chloroquine, enhanced puromycin aminonucleoside (PAN)-induced apoptosis of podocytes. In contrast, rapamycin-mediated promotion of autophagic activity decreased this apoptosis. In PAN-treated rats, inhibition of autophagy with 3-MA or chloroquine resulted in earlier onset and greater proteinuria, more extensive foot-process effacement, and reduction in podocyte markers, whereas rapamycin-mediated stimulation of autophagy led to decreased proteinuria and less severe foot-process effacement, but higher expression of podocyte markers. This study demonstrates that podocyte autophagic activity plays a critical protective role in renal injury and that maintaining podocyte autophagic activity represents a potential therapeutic strategy for controlling the progression of podocytopathies.Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.


Related Compounds

  • Rapamycin (Siroli...
  • Chloroquine diphos...
  • Stylomycin aminonu...
  • 3-Methyladenine

Related Articles:

Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.

2015-01-01

[Drug Des. Devel. Ther. 9 , 425-64, (2015)]

Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking.

2014-07-01

[Autophagy 10(7) , 1241-55, (2014)]

Lethality of PAK3 and SGK2 shRNAs to human papillomavirus positive cervical cancer cells is independent of PAK3 and SGK2 knockdown.

2015-01-01

[PLoS ONE 10(1) , e0117357, (2015)]

Short-term rapamycin treatment in mice has few effects on the transcriptome of white adipose tissue compared to dietary restriction.

[Mech. Ageing Dev. 140 , 23-9, (2014)]

AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathway.

2014-01-01

[PLoS ONE 9(12) , e114287, (2014)]

More Articles...